RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pharma-Bio Serv Stock

Pharma-Bio Serv ROE 2024

Pharma-Bio Serv ROE

0.08

Ticker

PBSV

ISIN

US71711N1000

In 2024, Pharma-Bio Serv's return on equity (ROE) was 0.08, a 33.63% increase from the 0.06 ROE in the previous year.

Pharma-Bio Serv Aktienanalyse

What does Pharma-Bio Serv do?

Pharma-Bio Serv Inc is an international company based in Puerto Rico that was founded in 1993. The company offers a wide range of high-quality services to the pharmaceutical, biotech, and hospital industries and has become a leading service provider in this field. Pharma-Bio Serv ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Pharma-Bio Serv's Return on Equity (ROE)

Pharma-Bio Serv's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Pharma-Bio Serv's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Pharma-Bio Serv's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Pharma-Bio Serv’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Pharma-Bio Serv stock

What is the ROE (Return on Equity) of Pharma-Bio Serv this year?

The ROE of Pharma-Bio Serv this year is 0.08 undefined.

How has the Return on Equity (ROE) of Pharma-Bio Serv developed compared to the previous year?

The ROE of Pharma-Bio Serv has increased by 33.63% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Pharma-Bio Serv?

A high ROE indicates that Pharma-Bio Serv generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Pharma-Bio Serv?

A low ROE can indicate that Pharma-Bio Serv is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Pharma-Bio Serv affect the company?

A change in ROE (Return on Equity) of Pharma-Bio Serv can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Pharma-Bio Serv?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Pharma-Bio Serv?

Some factors that can influence Pharma-Bio Serv's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Pharma-Bio Serv pay?

Over the past 12 months, Pharma-Bio Serv paid a dividend of 0.15 USD . This corresponds to a dividend yield of about 28.85 %. For the coming 12 months, Pharma-Bio Serv is expected to pay a dividend of 0.15 USD.

What is the dividend yield of Pharma-Bio Serv?

The current dividend yield of Pharma-Bio Serv is 28.85 %.

When does Pharma-Bio Serv pay dividends?

Pharma-Bio Serv pays a quarterly dividend. This is distributed in the months of January, March, April, February.

How secure is the dividend of Pharma-Bio Serv?

Pharma-Bio Serv paid dividends every year for the past 5 years.

What is the dividend of Pharma-Bio Serv?

For the upcoming 12 months, dividends amounting to 0.15 USD are expected. This corresponds to a dividend yield of 28.03 %.

In which sector is Pharma-Bio Serv located?

Pharma-Bio Serv is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pharma-Bio Serv kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pharma-Bio Serv from 2/15/2024 amounting to 0.075 USD, you needed to have the stock in your portfolio before the ex-date on 1/29/2024.

When did Pharma-Bio Serv pay the last dividend?

The last dividend was paid out on 2/15/2024.

What was the dividend of Pharma-Bio Serv in the year 2023?

In the year 2023, Pharma-Bio Serv distributed 0.075 USD as dividends.

In which currency does Pharma-Bio Serv pay out the dividend?

The dividends of Pharma-Bio Serv are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Pharma-Bio Serv

Our stock analysis for Pharma-Bio Serv Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharma-Bio Serv Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.